Dog on Colorado's Anschutz Medical Campus leading way on novel obsessive-compulsive disorder therapy treatment
It has become common for dogs to be used for a variety of behavioral health solutions, including those like post-traumatic stress disorder, for instance. But at the University of Colorado Anschutz Medical Campus, there is a single dog that is being used in a rather unique way: helping patients with obsessive compulsive disorder, or OCD, manage their symptoms.
Cate Rush, a social work fellow who works on the campus, has had Otis the Bernese Mountain Dog since her junior year of her undergraduate studies. He's helped in her in a variety of ways throughout her adult life, and she's now using him to help her patients as well.
Cate Rush with Otis
CBS
"I just feel like it's so special that he's able to do something that humans cannot," she said.
Otis is a trained therapy dog but works with a specific set of clients. Most of the patients that come see Cate have OCD.
"Therapy dogs aren't commonly used for OCD so it's been a bit of a learning experience how to use him," she said.
The research on the use of dogs for OCD patients is still evolving, as is most of the research around therapy dogs in general. It's only been since the turn of the 2000s that having dogs used as aids for behavioral health solutions has become more common. But it's rare to see one that is working with OCD patients. Otis is the only dog of his kind on the medical campus in Aurora.
Obsessive-compulsive disorder currently affects 2.5% of the United States population and can be treated with what is called exposure and response prevention therapy, or ERPT. It usually involves exposing patients to things that trigger their obsessive behaviors while giving them tools to help prevent them from engaging in their typical compulsions. A 2010 study by the University of Pennsylvania, cited in the National Institute of Health, showed that ERPT can significantly reduce OCD symptoms in up to 80% of patients.
CBS
That's where Otis comes in. He can help in a variety of ways, as a supportive and helpful sidekick to those being exposed to triggering things or situations or, in some cases, being a walking exposure therapy himself.
"There are a lot of patients who might have contamination fears," Rush said, "They can use him in exposure so I've had patients touch his paws or rub his belly."
"I had a patient and one of her final exposures in the IOP -- the intensive outpatient program -- was to high five Otis and that was really sweet," she added.
While Otis isn't part of any official research at Anschutz just yet, his presence signals an evolving approach to behavioral health solutions. One wag at a time.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
12 minutes ago
- Medscape
Key Abstracts in Early-Stage NSCLC From ASCO 2025
Dr Jonathan Goldman of the University of California, Los Angeles, highlights key abstracts in early-stage NSCLC from ASCO 2025. Dr Goldman begins with updated results from CheckMate 816, comparing neoadjuvant chemotherapy (chemo) vs chemo + nivolumab. Median overall survival (OS) in the nivolumab arm remains unreached vs 73.7 months with chemo alone. Event-free survival (EFS) is durable at 59.6 vs 21.1 months, as evidenced by 5-year EFS of 49% in the combination arm. Next, he reviews the NeoADAURA trial evaluating neoadjuvant osimertinib ± chemo in resectable EGFR-mutated stage II-IIIB NSCLC. Major pathologic response was higher in osimertinib-containing arms (26% and 25%) vs 2% in the chemo arm, although long-term outcomes remain pending. Dr Goldman also discusses the SWOG/NRG S1914 trial of perioperative stereotactic body radiotherapy ± atezolizumab, which did not show improvements in OS or progression-free survival (PFS). He then highlights a prospective, low-dose CT screening study of the Mississippi Delta cohort, which showed a 4.7% lung cancer detection rate overall and 4.5% in patients with incidental pulmonary nodules — underscoring the utility of low-dose CT as a modality in early detection. In closing, he reports on two studies in small cell lung cancer. The IMforte study showed that lurbinectedin + atezolizumab in 1L maintenance improved PFS (HR, 0.54). In the DeLLphi-304 study, second-line tarlatamab improved OS compared to chemo (HR, 0.6), which is a potentially practice-changing update.
Wall Street Journal
16 minutes ago
- Wall Street Journal
Health Insurers to Promise Changes to Preapproval Process That Drew Backlash
Following the backlash that hit health insurers after the killing of a top executive last year, the industry will pledge steps meant to smooth the controversial preapproval process that can deny or delay access to care. The initiative is set to be unveiled early next week, according to people familiar with the matter.
CBS News
23 minutes ago
- CBS News
Chicago officials detail preparation efforts, offer tips ahead of this weekend's extreme heat
With the extreme heat approaching, pools and waterparks will be busy, but according to city officials, taking a dip will not be the only precaution people will need this weekend. Scorching temperatures and high humidity are a bad combo, especially when that's the forecast for three days in a row, making heat stroke a real possibility. On Friday, city officials, including Mayor Brandon Johnson and the Office of Emergency Management and Communications, discussed the measures they're taking ahead of and during the first heat wave of the year. The city said it plans to operate cooling centers, but beware that many of them are only open on weekdays. In that case, libraries, park district buildings, and police stations are some spots where people can find some relief over the weekend. Officials also shared some alarming numbers showing how dangerous a heat wave can be. "Over the last three years, we have recorded 485 heat-related deaths in Chicago and more than 700 heat-related emergency department visits," Chicago Department of Public Health Commissioner Dr. Olusimbo Ige said. She added that men are more likely to experience a heat-related emergency than women. OEMC executive director Francisco Velez said they are monitoring the heat closely. "OEMC is working directly with the National Weather Center 24/7 to monitor the weather events and will alert residents if conditions worsen. OEMC is coordinating with city departments and sister agencies to ensure services and resources are available in response to the heat," he said. Mayor Johnson also stressed the importance of staying informed and checking on those with health conditions. "Over the next few days, make sure that we check in on our loved ones and neighbors, especially our seniors and those with health conditions, individuals with disabilities. We do have cooling locations all over the city, we have street outreach workers who are available as well to connect the unhoused Chicagoans with those resources," Johnson said. Doctors said seniors and anyone who takes beta blockers, diuretics, and sedatives are the most at risk. If you are worried about someone who lives in Chicago and can't make contact with them, you're encouraged to call 311 and request a well-being check.
